Amazon.it:Recensioni clienti: The Code Breaker
Passa al contenuto principale
.it
Ciao Scegli il tuo indirizzo
Tutte le categorie
Ciao, accedi
Account e liste
Resi e ordini
Carrello
Tutte
Supporto per l'accessibilità Bestseller Amazon Basics Offerte Servizio Clienti Musica Novità eBook in italiano Prime Videogiochi Libri Informatica Casa e cucina Elettronica Supermercato Moda Auto e Moto Giochi e Giocattoli Sport e Attività all'aperto Miglioramento casa Salute e cura della casa Bellezza Audible Prodotti per animali domestici Prima infanzia Buoni Regalo Idee regalo Vendere su Amazon Toolkit Acquirente Spedizione Gratuita
Spedizione gratuita sul tuo primo ordine

  • The Code Breaker
  • ›
  • Recensioni clienti

Recensioni clienti

4,7 su 5 stelle
4,7 su 5
11.509 valutazioni globali
5 stelle
75%
4 stelle
18%
3 stelle
5%
2 stelle
1%
1 stella
1%
The Code Breaker

The Code Breaker

daWalter Isaacson
Scrivi una recensione
Come funzionano le recensioni e le valutazioni dei clienti

Le recensioni dei clienti, comprese le valutazioni a stelle dei prodotti, aiutano i clienti ad avere maggiori informazioni sul prodotto e a decidere se è il prodotto giusto per loro.

Per calcolare la valutazione complessiva e la ripartizione percentuale per stella, non usiamo una media semplice. Piuttosto, il nostro sistema considera cose come quanto è recente una recensione e se il recensore ha acquistato l'articolo su Amazon. Ha inoltre analizzato le recensioni per verificarne l'affidabilità.

Maggiori informazioni su come funzionano le recensioni dei clienti su Amazon
Visualizza tutte le opzioni di acquisto

Accedi per filtrare le recensioni
11.509 valutazioni totali, 541 con recensioni

Al momento, si è verificato un problema durante il filtraggio delle recensioni. Riprova più tardi.

Traduci tutte le recensioni in Italiano

Da Italia

Ci sono 0 recensioni e 21 valutazioni dall'Italia

Da altri Paesi

Sandra Iler Kirkland
5,0 su 5 stelle An Overview Of The CRISPR Revolution
Recensito negli Stati Uniti 🇺🇸 il 3 gennaio 2023
Acquisto verificato
A biological revolution is occurring right now, one expected to be as impactful as the digital revolution. This book tells the story of that revolution and the players in it, especially Jennifer Doudna and her co-workers who discovered the breakthrough that allows CRISPR to exist and gives it the potential to fix defects in cells.
Doudna was determined to be a scientist from her teen years after reading James Watson's account of discovering and mapping human DNA. After college and her doctorate, she became interested in RNA and with the help of others was able to use it to cut out defective strings in DNA and replace it with the correct sequence. She and her French partner, another woman named Emmanuelle Charpentier won the Nobel Prize for this discovery and others in the field.

But all is not rosy in the CRISPR world. Although science has made breakthroughs throughout history due to collaboration and shared research, the awarding or prizes and patents has made the scientific world more capitalistic. Doudna beat out another team from Boston headed by Zheng Fang, by only a slight margin and tension between the two labs has continued for years.

There are many benefits to this discovery. Genetic diseases such as sickle cell anemia and Huntington's disease, which are caused by a single gene defect now have hopes of being cured. The work can be used to increase plant production and farm productivity, making food security more of a reachable goal. Cancer is another frontier that could benefit and only yesterday I read about CRISPR making breakthroughs in ALS, a degenerative nerve disease.

There are also ethical problems. One of the biggest is the decision to either work on genes that exist in a living person, which benefits that individual or using CRISPR to change inheritable DNA, which changes the entire human genome forever more. Is changing our genome something the human race is prepared to do without knowing all the repercussions it can cause? This is the field for enhancements such as greater muscle strength, appearance, and perhaps intelligence. Who would pay for this? Would it stretch the gap between poor and rich even further as the rich choose to give their children advantages poorer parents could only dream of?

Walter Issacson has been a journalist for many years, working on magazines such as Time. In recent years, he has worked on biographies of scientists in breaking news fields such as Steve Jobs and Einstein and those involved in the digital revolution. He also has written works on Leonardo da Vinci, Benjamin Franklin and Henry Kissinger. His work is detailed and he explains the science of the CRISPR world in a way that those not in the field can understand readily. This book is recommended for nonfiction readers.
8 persone l'hanno trovato utile
Segnala
Traduci recensione in Italiano
LA in Dallas
3,0 su 5 stelle I am not the target market for this book
Recensito negli Stati Uniti 🇺🇸 il 13 febbraio 2022
Acquisto verificato
The first thing that struck me as I began reading The Code Breaker was "I know these people!" Note 6 in chapter 4 ("The education of a biochemist") especially brought this home to me:

"6. Sharon Panasenko, “Methylation of Macromolecules during Development in Myxococcus xanthus,” Journal of Bacteriology, Nov. 1985"

I knew Sharon Panasenko. She and I overlapped in the close-knit Stanford Biochemistry Department, and after she left we were both members of the small community of myxobacteria researchers. It is even possible that I met Jennifer Doudna around this time, when I was a Stanford grad student and she a Pomona College chemistry undergrad in Sharon's lab. The book is full of names familiar to me, known to me by reputation or in a few cases personally. The only major player in the CRISPR story I know personally is Eric Lander. (By "know personally" I mean we worked in the same lab and had multiple conversations.) But I also know several of the minor players and have met and spoken with many of the older participants.

Doudna (whom I have never met) seems a quite familiar type of scientist to me. Although she is clearly an extraordinary biologist, there are hundreds of extraordinary biologists, and Doudna is extraordinary in an ordinary way -- that is, she is extraordinary in the same way that most extraordinary biologists are extraordinary. The best short description of her comes from her PhD mentor Jack Szostak, “Jennifer was fantastically good at the bench, because she was fast and sharp and could seemingly get anything to work,” Szostak says. “But we talked quite a bit about why the really big questions are the important questions.”

Let's dispose of the "big questions" cliche. Isaacson recounts the following:

"Szostak’s excitement about discovering how life began taught Doudna a second big lesson, in addition to taking risks by moving into new fields: Ask big questions."

"Ask big questions" is a cliche among scientists. I have heard versions of it hundreds of times. It is like a Disney Princess saying "True Love conquers all" or a coach in a Hollywood sports movie saying "You can do anything if you put your mind to it." It is not evidence of deep thought, but rather the opposite.

What's more, it is, like the Hollywood examples, problematic. The injunction to "ask big questions" mistakes the goal for the path. Clearly you want to ANSWER big questions. (And, to give credit where it's due, Szostak is one who has done that.) It is natural to think that the way to answer big questions is to ask big questions. Natural but wrong. The way to answer big questions is to ask little questions. Isaacson gives several examples, from Darwin asking "What birds live on the Galapagos Islands?" to Mendel's pea-breeding hobby. And the CRISPR story is a prime example of asking little questions. Who could forget the yogurt microbiologists? I could easily give dozens of examples from the history of science and mathematics, but you're already bored.

What Doudna is is "fantastically good at the bench, ... fast and sharp and [able] seemingly [to] get anything to work". She's a top-notch bench scientist. That is the ordinary way for an extraordinary biologist to be extraordinary.

It seems obvious to me that Isaacson chose to present Doudna this way. As he tells us early in the book, he wants to reveal some truths about how science is really done. Among these truths is that the myth of the hero-scientist is wrong and pernicious. (He doesn't say that in so many words -- this is my surmise.) Could Isaacson have written Doudna as a hero scientist? Well, what do you think? Isaacson is an accomplished biographer, who has written biographies of Einstein, Da Vinci, and Franklin. Could he have written a hero story for Doudna?

Of course he could. Hero-scientist stories persist not because they are true, but because they are entertaining. Isaacson wants us to know that biological research is a collective endeavor, and that you grossly misunderstand it if you make the players solitary heroes. In fact, as he writes later of a conversation at a CRISPR conference.

'“Is there any field that is more cutthroat and competitive than biological research?” one of the participants asks me after Zhang and Sternberg give their dueling talks. Well, yes, I think, almost every field can be, from business to journalism. What distinguishes biological research is the collaboration that is woven in. The camaraderie of being rival warriors in a common quest suffuses the Quebec conference.'

He is right!

The first quarter of the book describes how Charpentier and Doudna figured out CRISPR, culminating in the June 2012 paper. This is the best part of the book. After that we get into tedious wrangling when competitors leapt onto the discovery to develop methods for gene editing in humans. (For what it's worth, I personally am convinced that the Nobel Committee was right in giving credit to Doudna and Charpentier. After their work the applications were obvious and required no extraordinary tricks.) Doudna has a problem with private-sector work -- as recounted in the book, she twice had to give up participation in commercial research because it literally made her sick.

After the silly wrangling about credit for applications, we have two major sections of the book left: ethics and Covid. The ethics of gene editing is not a new question. I appreciated that Isaacson made an effort to present the question thoughtfully, without the performative appeal to rhetorical hysteria that contaminates so much of this discourse. On the other hand, if you have been following the question over the years there is nothing new in his discussion.

Covid doesn't really make sense as a part of the story Isaacson set out to tell. I have the feeling that when the pandemic struck Isaacson's journalistic instincts kicked in. Finding himself with extraordinary access (because of his work on the biography) to two labs that were mounting responses to Covid, he couldn't resist the temptation to report on it. But I have followed the technical side of the Covid story very closely since January 2020 and I'm bored with it.

So, that explains my headline. There were large parts of the book I didn't much appreciate because of who I am and what I already know. Others might enjoy it more.

I will say one thing for Isaacson: he gets stuff right. Although he necessarily simplifies the science at times, I never caught him doing it in a way that would cause serious misunderstanding. That is a rare thing in science popularization.
93 persone l'hanno trovato utile
Segnala
Traduci recensione in Italiano
tamano
5,0 su 5 stelle Tour de force as the record of life-science revolution, CRISPR-Cas9
Recensito in Giappone 🇯🇵 il 15 febbraio 2023
Acquisto verificato
Walter Isaacson's superb biography of Jennifer Doudna, who was awarded the 2020 Nobel Prize in Chemistry with Emmanuel Charpentier, contributed to finding the role of the tracrRNA required for gene editing. The author portrays other scientists whose shoulders Doudna and Charpentier stand on. Additionally, he devotes space to patents and prizes, especially the competition between Feng Zhang (张锋) at MIT and Doudna at UC Berkeley.
There are brief explanations that help us understand science. Still, you should have elementary knowledge of biology, such as the distinction between DNA and RNA, catalyst and enzyme, and bacteria and virus. Philosophy will help us think about ethical problems brought about by gene editing technology.
This book is all about science but somehow heartwarming, giving me great satisfaction.
Segnala
Traduci recensione in Italiano
Serghiou Const
5,0 su 5 stelle Gene editing in humans
Recensito nel Regno Unito 🇬🇧 il 24 novembre 2021
Acquisto verificato
For the first time in the evolution of life on this planet, a species (Homo sapiens) developed the capacity to edit its own genetic make up. It is now possible to carry out genome modifications in the germline that is in sperms, eggs and early stage embryos, thereby altering the genetic make up of every differentiated cell with the result that these changes will be passed on to the organism's progeny and all subsequent generations. It is only prudent that we now pause until the societal, ethical and philosophical implications of germline editing are properly and thoroughly discussed. I wish, however, to clarify that there has already been general acceptance of somatic editing that is changes that are made in targeted cells of a living patient and do not affect reproductive cells. If something goes wrong in these therapies, it can be disastrous for the individual but not the species.

The book covers, in chronological order, a time span of 160 years from Darwin's publication 'On the Origin of Species' in 1859 to the development of mRNA vaccines against the coronavirus in 2020.

A fascinating aspect is that the book is not written in the abstract but through the personalities of scientists involved in the race for gene editing, their cooperation, rivalries, patents, forming companies, therapies, prizes, moral issues and the corona virus.

The main rivalry was between Jennifer Doudna and her research associates at Berkeley and Feng Shang at the Broad Institute in Cambridge Massachusetts. The winner was Doudna who shared with Emmanuelle Charpentier the Nobel prize for chemistry in 2020.

A starting point leading to the discovery of the gene editing system is the year 1990 when Francisco Mojica in sequencing genome regions of archaea (a kind of bacteria), spotted fourteen identical DNA sequences which repeated at regular intervals and between them were 'spacer' segments. They seemed to be palindromes, meaning they read the same backward and forward. Searching the literature, he found that Yoshimuzi Ishino studying E. Coli, a very different bacteria, similarly spotted these repeated sequences and spacer segments. This convinced Mojica that the phenomenon must have some important biological significance. Mojica coined the acronym CRISPR, for 'clustered regularly interspersed short palindromic repeats.' In most organisms that had CRISPRs, the repeated sequences were flanked by one of several genes, which encoded directions for making an enzyme. These were named 'CRISPR - associated or Cas enzymes. What fascinated Mojica were the spacers, those regions of normal looking DNA segments that were nestled in between the repeated CRISPR segments. He took the spacer sequences of E. Coli and run them through databases. What he found was intriguing: the spacer segments matched sequences that were in viruses that attacked E. coli. He found the same thing when he looked at other bacteria with CRISPR sequences; their spacer segments matched those of viruses that attacked that bacteria. Mojica found that bacteria with CRISPR spacer sequences seemed to be immune from a virus that had the same sequence. But bacteria without the spacer were in fact infected. It was a pretty ingenious defense system, but there was something even cooler: it appeared to adapt to new threats. When new viruses came along, the bacteria that survived were able to incorporate some of that virus DNA and that create, in its progeny, an acquired immunity to that new virus.

Mojica published a paper with his findings which was the beginning of a wave of articles providing evidence that CRISPR was, indeed, an immune system that bacteria adapted whenever they got attacked by a new type of virus.

By 2009 there was consensus that the Cas 9 was the most interesting of the CRISPR - associated enzymes. Researchers had shown that if you deactivated Cas 9 in bacteria, no longer cut up the invading viruses. They had also established the essential role of another part of the complex: CRISPR RNA, known as crRNA. These are small snippets of RNA that contain some genetic coding from a virus that had attacked the bacteria in the past. This crRNA guides the Cas enzymes to attack that virus when t tries to invade again. These two elements are the core of the CRISPR system: a small snippet of RNA that acts as a guide and an enzyme that acts as scissors. But there was one additional element of the CRISPR - Cas9 system that played an essential role, in fact, two roles. It was dubbed as 'trans - activating CRISPR RNA' or tracrRNA, pronounced 'tracer - RNA.' First, it facilitates the making of crRNA sequence that carries the memory of a virus that previously attacked the bacteria. Then it serves as a handle to latch on the invading virus so that crRNA can target the right spot for the Cas9 enzyme to chop.

As I have indicated in the beginning of the review the CRISPR - Cas9 system has been adapted from bacteria to edit human genes.

The distinguished Israeli author, Yuval Noah Harari, has aptly remarked that Homo sapiens has become Homo Deus.
5 persone l'hanno trovato utile
Segnala
Traduci recensione in Italiano
Kai Lee
5,0 su 5 stelle Amazing guide to CRISPR-Cas 9 by a science historian
Recensito negli Stati Uniti 🇺🇸 il 18 marzo 2021
Acquisto verificato
The Nobel Prize in Physiology or Medicine in 1962 was awarded jointly to Francis Crick, James Watson and Maurice Wilkins “for their discoveries concerning the molecular structure of nucleic acids and its significance for information transfer in living material." However, it was only after the publication of the book “Double Helix” by Watson in 1968 that DNA became a household word and the world came to realize that it had entered the biomolecular age. More than half of a century later, in 2020, the Nobel Prize in chemistry was awarded to Emmanuelle Charpentier and Jennifer A. Doudna “for the development of a method for genome editing” This time, it took only a few months for the book “The Code-Breaker” by science historian Walter Isaacson to be published. Irrespective whether the hard-to-pronounce gene cutter, “CRISPR-Cas9” will become a household word, there is hardly any doubt that “the future of the Human Race” (the subtitle of the book), is at stake.

Although the main character of the book is Jennifer Doudna, the account of her journey in the discovery of CRISPR-Cas 9 involves a cast of amazing group of colleagues, collaborators and competitors. Foremost among them are her main collaborator Emmanuelle Charpentier and her main competitor Feng Zhang. Other interesting personalities include several scientists in her lab at Berkeley, Director of the MIT Broad Institute Eric Lander, Professor George Church of Harvard, to name just a few. Then there is the Chinese doctor He Jiankui, whose project on CRISPR babies Nana and Lulu brought him jail instead of glory, and the colorful biohacker Josiah Zayner, who wanted to demonstrate on YouTube how easy CRISPR is and to inspire people to do that at home.
The color photos throughout the book add to the liveliness of their stories.

The stories told in the book illustrate many characteristics common to scientists – ambitious, competitive, eager to be first and eager to be recognized, occasional selfishness but also capable of generosity. It is touching to see that, in fighting Covid 19, rival teams come together to collaborate and they made their findings freely available to the community instead of fighting for patents. It is timely to learn that the Covid mRNA vaccines developed is directly the result of the research that led to CRISPR.

Above all, scientists are driven by curiosity and the beauty of nature. Both the book and the author’s TV interviews cited Jennifer’s curiosity as a little girl growing up in Hilo, Hawaii, wondering why the fernlike leaves of “sleeping grass” curl up when touched. There was no mention in the book whether Jennifer found the biological mechanism which led to the leaves folding. It would be nice to add a sentence or two to explain the reason (for the un-initiated).

The scientists in the story are also keenly aware of the consequences of their discoveries to society and mankind. There were several conferences devoted to discuss the ethical and moral problems concerning gene-editing. Attempts were made to formulate guidelines in conducting future research, without noticeable success. The author presents a number of thought experiments to illustrate the complexity of these issues, which centered around under what circumstances is it ethical and moral to intervene with gene-editing. If it is up to me, I would say that absolute medical necessity and getting rid of unbearable suffering should be the main, if not the sole criteria.

The book ends with two moving stories, one joyful and one sad. The joyful one involves the reconciliation of Jennifer and Emmanuelle, who had drifted apart after their Nobel prize winning Discovery, due to differences in personality. The sad one concerns James Watson, who was ostracized by his own Institution, the Cold Spring Harbor Laboratory, for saying racially insensitive things.

There are memorable and provocative quotes in the book, two of which are given below:

“If man wants to play God, he has to first learn to be man.” - author unknown

“If scientists don’t play God, who will?” - James Watson

Finally, the author is to be complimented that, while he studied almost everything under the sun (history, literature, politics, philosophy and economics) in college, except science, he was able to guide the reader through the jungle of DNA, RNA, CRISPR, CAS, CARVER, PAC-MAN, etc. Most amazing of all, he even learned to use CRASPR-cas9 to edit.
21 persone l'hanno trovato utile
Segnala
Traduci recensione in Italiano
Hande Z
5,0 su 5 stelle All cut up
Recensito negli Stati Uniti 🇺🇸 il 24 maggio 2021
Acquisto verificato
There are several books on CRISPR and genetic engineering published in 2020 and 2021. It is almost as if the writers were racing against each other the way the scientists from Berkeley (Doudna & Co) and Zhang (MIT/Harvard) raced against each other, first in determining how to use CRISPR to edit the human gene, and later, in the race to file the patent for the procedure.

This book is 481 pages long but is an easy and exhilarating book written by an experienced hand. Issacson, however, openly declares that he tells the story primarily from Jennifer Doudna’s point of view. He has done his best to be an impartial reporter and recorder of the story, yet it is obvious, and perhaps unavoidable, that some characters are cast in poorer light against Doudna, who Issacson shines the light of sainthood upon.

Before the race to discover how CRISPR might be used on human genes, they first have to discover CRISPR – the acronym for Clustered Regularly Interspaced Short Palindromic Repeats. As it appears, scientific discoveries are made a step at a time, almost always by different scientists. The Japanese Yoshizumi Ishino was the first to discover the repeat structures in a bacteria. It was Francisco Mojica who realised what these do, and it was he who came up with the name CRSPR. Then came Jennifer Doudna and Emmanuelle Charpentier.

In brief, they discovered how bacteria defend themselves against their old enemy, the virus. The bacteria cut up some of the DNA from the virus and then implant them on themselves so that they can identify the invading virus when they attacked again.

The story continues to the crucial race to discover how exactly the bacteria cut up the virus DNA. That was main work of Doudna and Charpentier. They discovered the process through the RNA and how the TRACR RNA helps identity then guide the bacteria’s protein enzyme to the target. All that is exciting, yet the book’s attraction lies in many other aspects.

We see how fame and money (the scientists get millions of dollars from prizes) change or perhaps reveal the dark side of even the seemingly nicest of people. We see how quiet, unassuming, dedicated scientists turn to ego-sensitive, prize-grabbing people. We may also question the way the patent system works. Reading between the lines of this book (remember, Isaacsson is a little beholden to Doudna for the backbone of his story) we might get a slightly different take.

Ethical issues involve not only the big question as to whether we should allow genetic editing in humans, but also the subsidiary question, of when we are ready for it. Thus enters the Chinese scientist He Jiankui who used CRISPR to edit the genes of a pair of twins so that they are genetically resistant to the HIV virus. Yet He Jiankui created an uproar in the West, and the worldwide outrage led to him being found guilty of conducting experiments without official approval and was sentenced to three years jail. He rushed ahead before the all-clear signal.

But now, with the COVID pandemic, scientists are open to using gene editing as an answer. Furthermore, even Doudna is working on other diseases that can be cured. They include the sickle cell disease, Alzheimer’s, and also cancer. There are also problems that the present system has not yet addressed – gene-editing as a medical magic wand seems destined to be available only for the rich.

We also learn from this book that the US military, DARPA (Defense Advanced Research Projects Agency) was so very much interested in gene technology in the last six years or so that it invested US$65m into research involving CRISPR and genetic engineering specifically for military purposes. Doudna is in one of the seven teams involved with DARPA funded research.

The moral and ethical issues are enough to keep one thinking long after the last page is turned. One big question is how different are the modern-day eugenics different from the eugenics of the early 20th century?
6 persone l'hanno trovato utile
Segnala
Traduci recensione in Italiano
Donald Malnati
5,0 su 5 stelle Fascinating and well written story
Recensito negli Stati Uniti 🇺🇸 il 15 marzo 2023
Acquisto verificato
Initially i thought this was a biography, but it turned out to be a much larger and interesting story that includes a lot of biographical detail. The discovery of gene editing is an amazing feat and story, but the larger part of the story is what we do with that technology in the future. A lot to consider! And well presented by am excellent, thoughtful author.
Segnala
Traduci recensione in Italiano
Hande Z
5,0 su 5 stelle All cut up
Recensito a Singapore 🇸🇬 il 24 maggio 2021
Acquisto verificato
There are several books on CRISPR and genetic engineering published in 2020 and 2021. It is almost as if the writers were racing against each other the way the scientists from Berkeley (Doudna & Co) and Zhang (MIT/Harvard) raced against each other, first in determining how to use CRISPR to edit the human gene, and later, in the race to file the patent for the procedure.

This book is 481 pages long but is an easy and exhilarating book written by an experienced hand. Issacson, however, openly declares that he tells the story primarily from Jennifer Doudna’s point of view. He has done his best to be an impartial reporter and recorder of the story, yet it is obvious, and perhaps unavoidable, that some characters are cast in poorer light against Doudna, who Issacson shines the light of sainthood upon.

Before the race to discover how CRISPR might be used on human genes, they first have to discover CRISPR – the acronym for Clustered Regularly Interspaced Short Palindromic Repeats. As it appears, scientific discoveries are made a step at a time, almost always by different scientists. The Japanese Yoshizumi Ishino was the first to discover the repeat structures in a bacteria. It was Francisco Mojica who realised what these do, and it was he who came up with the name CRSPR. Then came Jennifer Doudna and Emmanuelle Charpentier.

In brief, they discovered how bacteria defend themselves against their old enemy, the virus. The bacteria cut up some of the DNA from the virus and then implant them on themselves so that they can identify the invading virus when they attacked again.

The story continues to the crucial race to discover how exactly the bacteria cut up the virus DNA. That was main work of Doudna and Charpentier. They discovered the process through the RNA and how the TRACR RNA helps identity then guide the bacteria’s protein enzyme to the target. All that is exciting, yet the book’s attraction lies in many other aspects.

We see how fame and money (the scientists get millions of dollars from prizes) change or perhaps reveal the dark side of even the seemingly nicest of people. We see how quiet, unassuming, dedicated scientists turn to ego-sensitive, prize-grabbing people. We may also question the way the patent system works. Reading between the lines of this book (remember, Isaacsson is a little beholden to Doudna for the backbone of his story) we might get a slightly different take.

Ethical issues involve not only the big question as to whether we should allow genetic editing in humans, but also the subsidiary question, of when we are ready for it. Thus enters the Chinese scientist He Jiankui who used CRISPR to edit the genes of a pair of twins so that they are genetically resistant to the HIV virus. Yet He Jiankui created an uproar in the West, and the worldwide outrage led to him being found guilty of conducting experiments without official approval and was sentenced to three years jail. He rushed ahead before the all-clear signal.

But now, with the COVID pandemic, scientists are open to using gene editing as an answer. Furthermore, even Doudna is working on other diseases that can be cured. They include the sickle cell disease, Alzheimer’s, and also cancer. There are also problems that the present system has not yet addressed – gene-editing as a medical magic wand seems destined to be available only for the rich.

We also learn from this book that the US military, DARPA (Defense Advanced Research Projects Agency) was so very much interested in gene technology in the last six years or so that it invested US$65m into research involving CRISPR and genetic engineering specifically for military purposes. Doudna is in one of the seven teams involved with DARPA funded research.

The moral and ethical issues are enough to keep one thinking long after the last page is turned. One big question is how different are the modern-day eugenics different from the eugenics of the early 20th century?
Segnala
Traduci recensione in Italiano
Susan
5,0 su 5 stelle A Text That Even An English Major Can Appreciate
Recensito negli Stati Uniti 🇺🇸 il 24 maggio 2022
Acquisto verificato
Though I gave this a 5-star review, It's not perfect. But for the sheer breadth and depth of information on Doudna and this topic, the book deserves full credit. Also, this book discusses complex scientific information with clarity and insight so that even an English major (word perp) can enjoy the discussion of the process and have their curiosity satisfied about gene editing, not an easy task -- but one that Isaacson does quite well.

I also love the evolution of discovery that Isaacson describes, and I love that he introduces the reader to all those participating as he tells this story, Doudna's story. He also describes the brutal competition of scientists and researchers and the dynamic of collaboration in that community. But he notes the change that occurred during and after the pandemic. As a reader, I had a true sense of how all the pieces fit together after I read this book. Isaacson addresses the "elephant in the room" in detail by discussing the potential benefit and horror of gene editing for humankind. He does this in a way with provocative questions and answers that reveals a careful and methodical researcher who has a good understanding of what's at stake. He distinguishes between "treatment and enhancement" with precision. Last, I love how he inserts Doudna's actions, reactions, and dialogue into this story in which she is the lead protagonist. He does a careful job of uncovering uncomfortable issues that occurred along the way of discovery. I'm left with the impression that Jennifer Doudna is a singular ethical and brilliant research scientist who has paved and continues to pave the way for young scientists, especially young women, to change the world, even as she has.

In discussing the different facets of collaboration, before and after Mar 2020, I love that he emphasizes the importance of a cross-discipline approach and how various perspectives and experiences contribute to discovery.

My only two complaints (and these may seem overly critical) are that Isaacson seems to be overly accommodating to certain men in the book who had sexist tendencies or who were more rogue than research, but I think he does this to show extreme objectivity. Sometimes, though, his commentary was too opinionated and complimentary, to make up for being objective, when it was best to let the reader come to their own conclusions. I didn't need to be told how wonderful this person was even though they had just shown themselves or even though they had just said or did something unethical. The other complaint is that Isaacson describes so much about his own life and opinions that whenever I read them, I would develop a twitch. I wanted to say, "Dude, how do you give your opinion without giving your opinion?" That's Reporting 101. And he didn't really have to describe a person's physicality quite so much. Do we really need to know about someone's "chipmunk-cheeked round face"? But I forgive him and recommend this book 100%.

One more thing, I love the he ends the book by describing a repaired exchange between Doudna and Charpentier. And I love that he gives full credit to Rosalind Franklin, and I love the spirit of hopefulness of what's possible for future generations that he leaves the reader with.
7 persone l'hanno trovato utile
Segnala
Traduci recensione in Italiano
David Elebute
5,0 su 5 stelle CRISPR is King!
Recensito negli Stati Uniti 🇺🇸 il 30 marzo 2023
Acquisto verificato
Beautifully written, understandable and inspiring.
I really liked some of the thoughts of how we will eventually use all these tools and really concerned about not leaving anyone behind.
Segnala
Traduci recensione in Italiano
  • ←Precedente
  • Successivo→

Hai bisogno del servizio clienti? Clicca qui
‹ Visualizza tutti i dettagli per The Code Breaker

Articoli visualizzati di recente e suggerimenti in primo piano
›
Visualizza o modifica la cronologia di navigazione
Dopo aver visualizzato le pagine di dettaglio del prodotto, guarda qui per trovare un modo facile per tornare alle pagine che ti interessano.

Torna su
Per conoscerci meglio
  • Opportunità di lavoro
  • Informazioni su Amazon
  • Sostenibilità
  • AGCM - Impegni Amazon Procedimento PS 11716
  • Amazon Science
Guadagna con Amazon
  • Vendi su Amazon
  • Vendi su Amazon Business
  • Vendi su Amazon Handmade
  • Vendi prodotti innovativi
  • Costruisci e proteggi il tuo marchio
  • Diventa affiliato
  • Logistica di Amazon
  • Pubblica con noi da indipendente
  • Promuovi i tuoi prodotti
  • Ospita un hub Amazon
  • ›Scopri di più su Make Money with Us
Metodi di pagamento Amazon
  • Metodi di pagamento
  • Convertitore di Valuta Amazon
  • Buoni Regalo
  • Ricarica online
  • Ricarica in cassa
Bisogno di aiuto?
  • Visualizza o traccia un ordine
  • Costi e modalità di spedizione
  • Amazon Prime
  • Restituisci o sostituisci articoli
  • Riciclo
  • I miei contenuti e dispositivi
  • App Amazon Mobile
  • Servizio Clienti
  • IVA e fatturazione
  • Garanzia legale
  • Australia
  • Brasile
  • Canada
  • Cina
  • Francia
  • Germania
  • Giappone
  • India
  • Messico
  • Paesi/Regioni Bassi
  • Polonia
  • Emirati Arabi Uniti
  • Regno Unito
  • Spagna
  • Singapore
  • Stati Uniti
  • Turchia
Amazon Advertising
Trova, attira e coinvolgi i clienti
Amazon Music
Streaming di milioni di
canzoni
AbeBooks
Libri, arte
& articoli da collezione
Audible
Download
Audiolibri
Amazon Web Services
Servizi Cloud
Scalabili
 
Amazon Warehouse
I nostri prodotti usati e ricondizionati
Book Depository
Libri con spedizione
gratuita in tutto il mondo
Kindle Direct Publishing
Pubblica i tuoi libri
in formato elettronico
Shopbop
Designer, Marche,
Fashion e stile
Amazon Business
Servizio per
clienti business
  • Condizioni generali di uso e vendita
  • Informativa sulla privacy
  • Area legale
  • Cookie
  • Pubblicità definita in base agli interessi
© 1996-2023 Amazon.com, Inc. o società affiliate